AU2002342485A1 - Streptococcus suis avirulent vaccine and uses in antibiotic design - Google Patents

Streptococcus suis avirulent vaccine and uses in antibiotic design

Info

Publication number
AU2002342485A1
AU2002342485A1 AU2002342485A AU2002342485A AU2002342485A1 AU 2002342485 A1 AU2002342485 A1 AU 2002342485A1 AU 2002342485 A AU2002342485 A AU 2002342485A AU 2002342485 A AU2002342485 A AU 2002342485A AU 2002342485 A1 AU2002342485 A1 AU 2002342485A1
Authority
AU
Australia
Prior art keywords
streptococcus suis
avirulent vaccine
antibiotic design
antibiotic
design
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002342485A
Inventor
Benoit D'amours
Marcelo Gottschalk
Josee Harel
Marylene Kobish
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite de Montreal
Original Assignee
Universite de Montreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite de Montreal filed Critical Universite de Montreal
Publication of AU2002342485A1 publication Critical patent/AU2002342485A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2002342485A 2001-11-23 2002-11-25 Streptococcus suis avirulent vaccine and uses in antibiotic design Abandoned AU2002342485A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33201201P 2001-11-23 2001-11-23
US60/332,012 2001-11-23
PCT/CA2002/001796 WO2003046183A2 (en) 2001-11-23 2002-11-25 Streptococcus suis avirulent vaccine and uses in antibiotic design

Publications (1)

Publication Number Publication Date
AU2002342485A1 true AU2002342485A1 (en) 2003-06-10

Family

ID=23296331

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002342485A Abandoned AU2002342485A1 (en) 2001-11-23 2002-11-25 Streptococcus suis avirulent vaccine and uses in antibiotic design

Country Status (2)

Country Link
AU (1) AU2002342485A1 (en)
WO (1) WO2003046183A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0801326D0 (en) 2008-01-24 2008-03-05 Animal Health Trust Vaccines
CN112694988B (en) * 2020-12-15 2022-12-06 武汉市农业科学院 Chicken source streptococcus suis attenuated strain and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5587305A (en) * 1993-12-06 1996-12-24 The United States Of America As Represented By The Department Of Agriculture Pasteurella haemolytica transformants
EP1098980B1 (en) * 1998-07-22 2014-09-03 Stichting Dienst Landbouwkundig Onderzoek Streptococcus suis vaccines and diagnostic tests
WO2000068243A1 (en) * 1999-05-07 2000-11-16 Smithkline Beecham Corporation Methods using mechanisms of action of aroa

Also Published As

Publication number Publication date
WO2003046183A2 (en) 2003-06-05
WO2003046183A3 (en) 2004-03-11

Similar Documents

Publication Publication Date Title
AU2002225681A1 (en) Yeast-dentritic cell vaccines and uses thereof
EP1363925B8 (en) Macrolide antibiotics
AU2001287898A1 (en) Pyrazolopyridines and pyrazolopyridazines as antidiabetics
AU2003299535A1 (en) Group b streptococcus vaccine
AU2002217277A1 (en) Macrolide antibiotics
AU2001247478A1 (en) Microlaboratory devices and methods
AU2002319320A1 (en) Substituted isoxazoles and the use thereof as antibiotics
AUPR298901A0 (en) Cell suspension preparation technique and device
AU2001272719A1 (en) Macrolide antibiotics
AU2002213355A1 (en) Wireless asp systems and methods
AU2002302419A1 (en) Substituted Pyrazolopyrimidines and thiazolopyrimidines used as analgesics
AU2001272011A1 (en) Siderophores-producing bifidobacteria thereby and uses thereof
AU2002211717A1 (en) Stresscopins and their uses
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2001229439A1 (en) Bioconjugates and uses thereof
AU2002367969A1 (en) Toxin-phage bacteriocide antibiotic and uses thereof
AU2002243314A1 (en) Immunogenic cancer peptides and uses thereof
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2002342485A1 (en) Streptococcus suis avirulent vaccine and uses in antibiotic design
AU2001261317A1 (en) Immunostimulant compositions and associated methods
AU2002223344A1 (en) Sputum fixative and methods and uses therefor
AU2002346600A1 (en) 11-o-substituted macrolides and their descladinose derivatives
AU2001268053A1 (en) Human sparc-homologous (hsparc-h1) gene and methods and uses thereof
AU2002216863A1 (en) Streptococcus pyogenes antigens and corresponding DNA fragments
AU2002256556A1 (en) Sea-trosy and related methods

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase